by TractManager | Dec 19, 2019 | Emerging Technology Report
The WavelinQ endoAVF system is a catheter-based system for the endovascular creation of an arteriovenous fistula (AVF) in patients requiring hemodialysis. The system consists of a pair of over-the-wire catheters with magnets arranged to pull them into alignment and...
by TractManager | Dec 17, 2019 | Emerging Technology Report
The Monarch eTNS is an external trigeminal nerve stimulator for the treatment of attention-deficit/ hyperactivity disorder (ADHD) in children aged 7 to 12 years who are not currently taking prescription ADHD medication. If you have a Hayes login, click here to view...
by TractManager | Dec 17, 2019 | Emerging Technology Report
The Monarch eTNS is an external trigeminal nerve stimulator for the treatment of attention-deficit/ hyperactivity disorder (ADHD) in children aged 7 to 12 years who are not currently taking prescription ADHD medication. If you have a Hayes login, click here to view...
by TractManager | Dec 16, 2019 | Emerging Technology Report
Vyondys 53 is an antisense oligonucleotide of the phosphorodiamidate morpholino oligomer subclass intended to skip exon 53 of the DMD gene and enable the synthesis of a truncated but functional dystrophin protein. Only patients with Duchenne muscular dystrophy...
by TractManager | Dec 13, 2019 | Emerging Technology Report
Inrebic is an oral kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.If you have a Hayes login, click here to view the full...
Recent Comments